A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides (original) (raw)

• Polymeropoulos, M.H. et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045–2047 (1997).
  Article CAS Google Scholar
• Spillantini, M.G. et al. α-synuclein in Lewy bodies. Nature 388, 839–840 (1997).
  Article CAS Google Scholar
• Kruger, R. et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18, 106–108 (1998).
  Article CAS Google Scholar
• El-Agnaf, O.M., Jakes, R., Curran, M.D. & Wallace, A. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease. FEBS Lett. 440, 67–70 (1998).
  Article CAS Google Scholar
• Giasson, B.I., Uryu, K., Trojanowski, J.Q. & Lee, V.M. Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro. J. Biol. Chem. 274, 7619–7622 (1999).
  Article CAS Google Scholar
• Narhi, L. et al. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J. Biol. Chem. 274, 9843–9846 (1999).
  Article CAS Google Scholar
• Spillantini, M.G. & Goedert, M. The α-synucleinopathies: Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. Ann. NY Acad. Sci. 920, 16–27 (2000).
  Article CAS Google Scholar
• Singleton, A.B. et al. α-synuclein locus triplication causes Parkinson's disease. Science 302, 841 (2003).
  Article CAS Google Scholar
• Chartier-Harlin, M.C. et al. α-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364, 1167–1169 (2004).
  Article CAS Google Scholar
• Ibanez, P. et al. Causal relation between α-synuclein gene duplication and familial Parkinson's disease. Lancet 364, 1169–1171 (2004).
  Article CAS Google Scholar
• Masliah, E. et al. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265–1269 (2000).
  Article CAS Google Scholar
• Lee, M.K. et al. Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice. Proc. Natl. Acad. Sci. USA 99, 8968–8973 (2002).
  Article CAS Google Scholar
• Fernagut, P.O. & Chesselet, M.F. α-synuclein and transgenic mouse models. Neurobiol. Dis. 17, 123–130 (2004).
  Article CAS Google Scholar
• Snyder, H. & Wolozin, B. Pathological proteins in Parkinson's disease: focus on the proteasome. J. Mol. Neurosci. 24, 425–442 (2004).
  Article CAS Google Scholar
• Springer, W. & Kahle, P.J. Mechanisms and models of α-synuclein–related neurodegeneration. Curr. Neurol. Neurosci. Rep. 6, 432–436 (2006).
  Article CAS Google Scholar
• Chandra, S., Gallardo, G., Fernandez-Chacon, R., Schluter, O.M. & Sudhof, T.C. α-synuclein cooperates with CSPα in preventing neurodegeneration. Cell 123, 383–396 (2005).
  Article CAS Google Scholar
• Corder, E.H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 261, 921–923 (1993).
  Article CAS Google Scholar
• Huang, X., Chen, P.C. & Poole, C. APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease. Neurology 62, 2198–2202 (2004).
  Article CAS Google Scholar
• Li, Y.J. et al. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology 62, 2005–2009 (2004).
  Article CAS Google Scholar
• Tsuang, D.W. et al. Familial dementia with lewy bodies: a clinical and neuropathological study of two families. Arch. Neurol. 59, 1622–1630 (2002).
  Article Google Scholar
• Horsburgh, K., Graham, D.I., Stewart, J. & Nicoll, J.A. Influence of apolipoprotein E genotype on neuronal damage and apoE immunoreactivity in human hippocampus following global ischemia. J. Neuropathol. Exp. Neurol. 58, 227–234 (1999).
  Article CAS Google Scholar
• Mahley, R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622–630 (1988).
  Article CAS Google Scholar
• Ma, J., Yee, A., Brewer, H.B. Jr., Das, S. & Potter, H. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92–94 (1994).
  Article CAS Google Scholar
• Brecht, W.J. et al. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J. Neurosci. 24, 2527–2534 (2004).
  Article CAS Google Scholar
• Strittmatter, W.J. et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 11183–11186 (1994).
  Article CAS Google Scholar
• Boillee, S. et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389–1392 (2006).
  Article CAS Google Scholar
• Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493–506 (1996).
  Article CAS Google Scholar
• Schmued, L.C. & Hopkins, K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874, 123–130 (2000).
  Article CAS Google Scholar
• Mahley, R.W., Weisgraber, K.H. & Huang, Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. USA 103, 5644–5651 (2006).
  Article CAS Google Scholar
• Ignatius, M.J. et al. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. USA 83, 1125–1129 (1986).
  Article CAS Google Scholar
• DeMattos, R.B. et al. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 99, 10843–10848 (2002).
  Article CAS Google Scholar
• Roy, S., Zhang, B., Lee, V.M. & Trojanowski, J.Q. Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol. 109, 5–13 (2005).
  Article Google Scholar
• Holtzman, D.M. In vivo effects of ApoE and clusterin on amyloid-β metabolism and neuropathology. J. Mol. Neurosci. 23, 247–254 (2004).
  Article CAS Google Scholar
• Tandon, A., Rogaeva, E. & Mullan, M. St George-Hyslop, P.H. Molecular genetics of Alzheimer's disease: the role of β-amyloid and the presenilins. Curr. Opin. Neurol. 13, 377–384 (2000).
  Article CAS Google Scholar
• Piedrahita, J.A., Zhang, S.H., Hagaman, J.R., Oliver, P.M. & Maeda, N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA 89, 4471–4475 (1992).
  Article CAS Google Scholar
• Coleman, M. Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 6, 889–898 (2005).
  Article CAS Google Scholar
• Hall, S.M. Observations on the progress of Wallerian degeneration in transected peripheral nerves of C57BL/Wld mice in the presence of recruited macrophages. J. Neurocytol. 22, 480–490 (1993).
  Article CAS Google Scholar
• Chen, L., Thiruchelvam, M.J., Madura, K. & Richfield, E.K. Proteasome dysfunction in aged human α-synuclein transgenic mice. Neurobiol. Dis. 23, 120–126 (2006).
  Article CAS Google Scholar
• Nonaka, T., Iwatsubo, T. & Hasegawa, M. Ubiquitination of α-synuclein. Biochemistry 44, 361–368 (2005).
  Article CAS Google Scholar
• Fagan, A.M. et al. Human and murine ApoE markedly alters Aβ metabolism before and after plaque formation in a mouse model of Alzheimer's disease. Neurobiol. Dis. 9, 305–318 (2002).
  Article CAS Google Scholar
• Dolev, I. & Michaelson, D.M. A nontransgenic mouse model shows inducible amyloid-β (Aβ) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc. Natl. Acad. Sci. USA 101, 13909–13914 (2004).
  Article CAS Google Scholar
• Kuo, Y.M. et al. Elevated Aβ and apolipoprotein E in A βPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease. Mol. Med. 6, 430–439 (2000).
  Article CAS Google Scholar
• Bales, K.R. et al. Lack of apolipoprotein E dramatically reduces amyloid β–peptide deposition. Nat. Genet. 17, 263–264 (1997).
  Article CAS Google Scholar
• Masliah, E. β-amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc. Natl. Acad. Sci. USA 98, 12245–12250 (2001).
  Article CAS Google Scholar
• Rosahl, T.W. et al. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 375, 488–493 (1995).
  Article CAS Google Scholar
• Ihara, M. et al. Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of α-synuclein neurotoxicity. Neuron 53, 519–533 (2007).
  Article CAS Google Scholar
• Dewachter, I. et al. Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1. J. Neurosci. 20, 6452–6458 (2000).
  Article CAS Google Scholar